On the recordMarch 30, 2023
In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.
Source
congress.govIn the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.
Discusses findings from an investigation into insulin pricing.
Share
More from Chuck Grassley
What I’ve uncovered today is disturbing and outrageous political conduct by the Biden FBI